Post-IPO Equity - Syros Pharmaceuticals
Investment Firm
Overview
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Announced Date
Dec 19, 2023
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
7
Round Details and Background
Syros Pharmaceuticals raised $45000000 on 2023-12-19 in Post-IPO Equity
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Company Funding History
11
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Apr 26, 2017 |  Post-IPO Equity - Syros Pharmaceuticals | - | 35.0M | |
| Jan 12, 2016 | Series C - Syros Pharmaceuticals | 8 | - | 40.0M |
| Oct 27, 2014 | Series B - Syros Pharmaceuticals | 7 | - | 53.0M |
| Apr 11, 2013 | Series A - Syros Pharmaceuticals | 2 | - | 30.0M |
Recent Activity
There is no recent news or activity for this profile.